Follow
Yu Ri Nam
Title
Cited by
Cited by
Year
Microfluidic single-cell proteomics assay chip: Lung cancer cell line case study
Y Jung, M Son, YR Nam, J Choi, JR Heath, S Yang
Micromachines 12 (10), 1147, 2021
32021
In vivo genome editing using 244-cis LNPs and low-dose AAV achieves therapeutic threshold in hemophilia A mice
JP Han, Y Lee, JH Lee, HY Chung, GS Lee, YR Nam, M Choi, KS Moon, ...
Molecular Therapy-Nucleic Acids 34, 2023
22023
Bioorthogonal CRISPR/Cas9‐Drug Conjugate: A Combinatorial Nanomedicine Platform
MJ Beha, JC Kim, SH Im, Y Kim, S Yang, J Lee, YR Nam, H Lee, HS Park, ...
Advanced Science 10 (27), 2302253, 2023
22023
Distinguishing between DNA-Loaded Full and Empty Capsids of Adeno-Associated Virus with Atomic Force Microscopy Imaging
YR Nam, HH Ju, J Lee, D Lee, Y Kim, SJ Lee, HK Kim, JH Jang, H Lee
Langmuir 39 (19), 6740-6747, 2023
22023
Cyclin-dependent kinase inhibitor BMI-1026 induces apoptosis by downregulating mcl-1 (L) and c-FLIP (L) and inactivating p-akt in human renal carcinoma cells
DE Kim, J Lee, JW Park, H Kang, YR Nam, TK Kwon, KS Kim, S Kim
International Journal of Molecular Sciences 22 (8), 4268, 2021
22021
A Bioorthogonal CRISPR-drug Conjugate Platform for Combinatorial Therapy
MJ BEHA, KIM Joo-Chan, IM San Hae, KIM Yunsu, Y Seungju, LEE Juhee, ...
한국생물공학회 학술대회, 621-621, 2023
2023
The system can't perform the operation now. Try again later.
Articles 1–6